[go: up one dir, main page]

WO2018166362A1 - 药物监测装置、系统及方法 - Google Patents

药物监测装置、系统及方法 Download PDF

Info

Publication number
WO2018166362A1
WO2018166362A1 PCT/CN2018/077896 CN2018077896W WO2018166362A1 WO 2018166362 A1 WO2018166362 A1 WO 2018166362A1 CN 2018077896 W CN2018077896 W CN 2018077896W WO 2018166362 A1 WO2018166362 A1 WO 2018166362A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
type
subunit
container
medicine
Prior art date
Application number
PCT/CN2018/077896
Other languages
English (en)
French (fr)
Inventor
张凯亮
Original Assignee
京东方科技集团股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 京东方科技集团股份有限公司 filed Critical 京东方科技集团股份有限公司
Priority to US16/087,378 priority Critical patent/US20190086326A1/en
Publication of WO2018166362A1 publication Critical patent/WO2018166362A1/zh

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/02—Pill counting devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/70—Device provided with specific sensor or indicating means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/70—Device provided with specific sensor or indicating means
    • A61J2200/74—Device provided with specific sensor or indicating means for weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
    • A61J7/0436—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system resulting from removing a drug from, or opening, a container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0454—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers for dispensing of multiple drugs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Definitions

  • the present disclosure relates to a drug monitoring device, system and method.
  • a drug monitoring device comprising: a drug analyzer configured to detect a type parameter and a quantity parameter of a drug and a processing module coupled to the drug analyzer.
  • the processing module is configured to: determine the type and quantity of the detected drug based on the type parameter and the quantity parameter of the detected drug, obtain the type and quantity of the preset drug, and determine whether the type and quantity of the detected drug are pre- The type and quantity of the drugs are matched.
  • the pharmaceutical analyzer is configured to detect a type parameter and a quantity parameter of the drug placed in the medicated container.
  • the drug analyzer is configured to detect a type parameter and a quantity parameter of the drug taken out of the container.
  • the drug analyzer includes: a Raman analyzer including a laser and a laser detecting device, wherein the laser emitted by the laser is capable of illuminating the surface of the drug, and the laser detecting device is capable of receiving the reflected laser And obtaining a spectrum of the drug; and a weight meter configured to detect the weight of the drug in the container.
  • the drug monitoring device further includes the medicated container, wherein the medicated container includes at least one subunit for holding a drug, wherein each subunit is provided with a through hole and has a corresponding setting Laser and laser detecting device, the laser being configured to emit laser light to the surface of the drug in the subunit through the through hole, the laser detecting device capable of receiving the laser light reflected back through the through hole and obtaining the subunit A spectrum of the drug; wherein each subunit has a correspondingly set weight and is configured to detect the weight of the drug in the subunit.
  • the drug monitoring device further includes a storage module in which a spectrum and a single piece weight of the plurality of drugs are pre-stored.
  • the processing module is further configured to determine a type of the drug in the subunit based on a detected match between a spectrum of the drug in each subunit and a spectrum of the pre-stored drug, The amount of the drug in the subunit is calculated using the detected weight of the drug in the subunit and the weight of the drug of the type to determine the type and amount of the drug placed in the container.
  • the processing module is further configured to be based on the user's take-out operation Detecting a match between the spectrum of the drug in each subunit and the spectrum of the pre-stored drug to determine the type of drug in the subunit, according to the type of the subunit detected before the user's fetch operation
  • the weight of the drug, the weight of the drug of the type in the subunit detected after the user's take-out operation, and the weight of the tablet of the type of drug, the amount of the drug of the type taken out is calculated, thereby determining the drug The type and amount of medication removed from the container.
  • each subunit is configured to allow only one piece of medicine to be placed, the processing module being further configured to: in response to the weight of the medicine in the subunit detected after the user's take-out operation is zero, The type and amount of the medicine taken out from the subunit is determined based on the type of the medicine in the subunit detected before the user's take-out operation, thereby determining the type and amount of the medicine taken out from the medicine container.
  • the processing module is configured to output a cue signal in response to determining that the type and amount of the detected drug does not match the type and amount of the pre-set drug.
  • the medication monitoring apparatus further includes: a prompting module coupled to the processing module, configured to present a prompt to the user based on the prompting signal output by the processing module.
  • the medication monitoring apparatus further includes a communication module coupled to the processing module, configured to: transmit a prompt signal output by the processing module to the electronic device in communication with the medication monitoring device, and receive the transmission from the electronic device Taking medication information, wherein the medication information includes at least the time of taking the medicine, the type and amount of the medication taken.
  • a medication monitoring system comprising a medication monitoring device as described above and an electronic device in communication with the medication monitoring device, wherein the medication monitoring device interacts with the electronic device via the communication device.
  • a medicine monitoring method comprising the steps of: determining a type and a quantity of a medicine to be placed in a medicine container; and determining whether the type and quantity of the medicine placed in the medicine container are determined to be The type and quantity of the preset drugs are matched; the first prompt is output in response to the determination that the type and quantity of the medicines placed in the container are not consistent with the type and quantity of the preset medicines.
  • the drug monitoring method further comprises: outputting a second prompt in response to determining that more than two drugs are included in each of the at least one subunit in the container.
  • a medicine monitoring method comprising: determining a type and a quantity of a medicine taken out from a medicine container; and determining whether the type and quantity of the medicine taken out from the medicine container are determined The type and quantity of the drug are set to match; in response to the determination that the type and amount of the drug taken out of the container are not consistent with the type and amount of the predetermined drug, the first prompt is output.
  • the drug monitoring method further comprises: outputting a second prompt in response to determining that more than two drugs are included in each of the at least one subunit in the container.
  • the drug monitoring method further comprises: in response to determining that no drug is removed from the drug container, issuing a third prompt message.
  • FIG. 1 is a block diagram showing an exemplary structure of a medication monitoring device in accordance with some embodiments of the present disclosure
  • FIG. 2 is an exemplary structural block diagram of a medication monitoring device in accordance with some embodiments of the present disclosure
  • FIG. 3 is an exemplary structural block diagram of a medication monitoring system in accordance with some embodiments of the present disclosure.
  • FIG. 4 is a top plan view of an exemplary structure of a drug holding container of a drug monitoring device, in accordance with some embodiments of the present disclosure
  • FIG. 5 is a schematic flow diagram of a drug monitoring method in accordance with some embodiments of the present disclosure.
  • FIG. 6 is a schematic flow diagram of a drug monitoring method in accordance with some embodiments of the present disclosure.
  • FIG. 7 is a schematic flow diagram of a drug monitoring method in accordance with some embodiments of the present disclosure.
  • FIG. 1 shows an exemplary structural block diagram of a medication monitoring device 100 in accordance with some embodiments of the present disclosure.
  • the device 100 includes a drug analyzer 40 and a processing module 20.
  • the drug analyzer 40 is capable of detecting the type parameter and the quantity parameter of the drug.
  • the processing module 20 is coupled to the drug analyzer 40, and is capable of determining the type and quantity of the detected drug based on the type parameter and the quantity parameter of the detected drug, obtaining the type and quantity of the preset drug, and determining the detected drug. Whether the type and quantity match the type and quantity of the preset drug.
  • the drug analyzer 40 can detect the type and quantity parameters of the drug placed in the medicated container (not shown in Figure 1).
  • the processing module 20 can determine the type parameter and the quantity of the medicine placed in the medicine container according to the type parameter and the quantity parameter of the medicine placed in the medicine container (not shown in FIG. 1) detected by the medicine analyzer 40, And determining whether the type parameter and quantity of the medicine placed in the medicine container coincide with the type and quantity of the preset medicine.
  • the drug analyzer 40 can detect the type parameter and quantity parameters of the drug taken from the container. Here, it can be determined by detecting the type parameter and the quantity parameter of the original drug in the container and the type parameter and the quantity parameter of the drug in the container after the take-out operation and comparing these parameters.
  • the processing module 20 can determine the type and quantity of the medicine taken out from the medicine container according to the type parameter and the quantity parameter of the medicine taken out from the medicine container detected by the medicine analyzer 40, and judge the type taken out from the medicine container. Whether the type and amount of the drug is consistent with the type and quantity of the drug.
  • FIG. 2 shows an exemplary structural block diagram of a medication monitoring device 200 in accordance with some embodiments of the present disclosure.
  • the drug monitoring device 200 includes a processing module 20 and a drug analyzer 40.
  • the drug analyzer 40 may include, for example, a Raman analyzer 41 and a weight meter 42.
  • the Raman analyzer 41 may include a laser 411 and a laser detecting device 412.
  • the laser light emitted by the laser 411 can be irradiated onto the surface of the drug.
  • the laser detecting device 412 is capable of receiving laser light reflected back by, for example, the drug in the drug container 10 and obtaining a spectrum of the drug as a type parameter for the processing module 20 to use to determine the type of the irradiated drug.
  • the weight meter 42 is used, for example, to collect the weight of the drug in the drug container 10 as a quantity parameter for the processing module 20 to use to determine the amount of the irradiated drug.
  • the processing module 20 can obtain the type parameter and the quantity parameter of the medicine detected by the Raman analyzer 41 and the weight meter 42 in the medicine analyzer 40, and obtain the type parameter and the quantity parameter of the medicine and the preset type parameter (for example, The set spectrum is compared to the quantity parameter (preset drug tablet weight) to determine the type and amount of drug detected.
  • the processing module 20 may further compare the determined type and quantity of the detected drugs with the type and quantity of the preset drugs to determine whether the type and quantity of the detected drugs are consistent with the type and quantity of the preset drugs. .
  • the drug monitoring device 200 can also include a drug holding container 10 for holding a drug.
  • the drug container 10 can include at least one subunit 11 for holding a drug.
  • Each of the subunits 11 can be used, for example, to hold the same kind of medicine, but is not limited thereto.
  • Each subunit can be used to hold different types of drugs.
  • Each of the sub-units 11 is provided with a through hole 12 and has a correspondingly disposed laser 411 and a laser detecting device 412 configured to emit laser light through the through hole 12 to the surface of the drug in the sub-unit 11, laser detection
  • the device 412 is capable of receiving the laser light reflected back through the through hole 12 and obtaining a spectrum of the drug in the subunit 11.
  • the through hole 12 is provided at the bottom of the subunit 11.
  • a plurality of lasers 411 may be disposed and the laser 411 may be disposed corresponding to each of the sub-units 11.
  • the laser 411 is used to emit laser light through the through hole 12 to the surface of the drug in the subunit 11.
  • the through holes 12 respectively formed at the bottoms of the respective subunits 11 may have a specific size.
  • the size of the through hole 12 can be set according to the size of the actual drug shape, ensuring that the laser can be irradiated to the surface of the drug through the laser, and that the drug does not leak from the through hole 12.
  • the processing module 20 can acquire the type of the drug in each of the subunits 11 by, for example, a Raman analyzer 41 (for example, including the laser 11 and the laser detecting device 412) by the following procedure.
  • the laser 411 located at the bottom of the subunit 11 emits laser light, and the laser light can be irradiated onto the medicine in the subunit 11 through the through hole 12 provided at the bottom of the subunit 11.
  • the laser hits the tablet.
  • the laser can hit any one of the tablets, that is, all the tablets can be hit.
  • reflection occurs after the laser hits the drug, and the reflected light is received by the laser detecting device 412.
  • the Raman analyzer 41 analyzes the reflected light using the Raman scattering principle to obtain a Raman spectrum of the drug.
  • the processing module 20 can compare the Raman spectra obtained by the Raman analyzer 41 with a predetermined library of drug spectra to determine the type of drug in the subunit 11.
  • the predetermined drug spectrum library may be obtained, for example, from an external database, or may be stored in advance, for example, in the storage module 50.
  • the drug types in the respective subunits 11 can be acquired simultaneously or sequentially.
  • Each subunit 11 may have a correspondingly set weight meter configured to detect the weight of the drug in the subunit. That is, a plurality of weight gauges 42 may be provided and the weight gauge 42 may be provided corresponding to each of the sub-units 11. The weight meter 42 collects the weight of the drug in the subunit 11.
  • the processing module 20 can acquire the amount of the medicine in each of the subunits 11 by, for example, the following procedure using the weight meter 42.
  • the weight meter 42 detects the weight of the drug in the subunit 11, and the processing module 20 utilizes the type of drug in the subunit 11 determined as described above, the weight of the drug in the subunit 11 detected by the weight 42, and The amount of the drug in the subunit 11 is calculated by a predetermined piece weight of the drug of this type.
  • the processing module 20 can acquire the amount of the medicine taken out from each of the subunits 11 by, for example, the following procedure using the weight meter 42.
  • the weight meter 42 detects the weight of the drug in the subunit 11 prior to the fetch operation and the weight of the drug in the subunit 11 after the fetch operation, and the processing module 20 utilizes the type of drug in the subunit 11 determined as described above, The weight difference of the medicine in the sub-unit 11 before and after the take-out operation detected by the weight meter 42 and the predetermined piece weight of the medicine of the type are determined to calculate the amount of the medicine taken out from the sub-unit 11.
  • the processing module 20 first determines the type of drug contained in each subunit 11 using a drug analyzer, and collects the weight of the drug in each subunit 11 using the weight meter 42 on the premise of the known drug class. Information (eg total weight of the drug). The amount of each drug is then obtained by dividing the total weight of the drug by the weight of the single piece based on the predetermined piece weight information of each drug.
  • the processing module 20 may determine the type of the drug in the subunit 11 based on the detected match between the spectrum of the drug in each subunit 11 and the spectrum of the pre-stored drug, using the detected The weight of the drug in the subunit 11 and the weight of the drug of the type of drug are used to calculate the amount of the drug in the subunit 11, thereby determining the type and amount of the drug placed in the container 10.
  • the drug analyzer is configured to detect a type parameter (eg, a spectrum) and a quantity parameter (eg, weight) of the drug removed from the drug container 10, and the processing module 20 can be configured to be based on the user's take-out operation
  • the type of drug in the subunit 11 is determined by matching between the spectrum of the drug in each subunit 11 previously detected and the spectrum of the pre-stored drug, according to the subunit 11 detected before the user's take-out operation.
  • the weight of the drug of this type, the weight of the drug of the type detected in the subunit after the user's removal operation, and the weight of the tablet of the type of drug, the number of drugs of that type taken out is calculated, thereby
  • the type and amount of the drug taken out from the container 10 is determined.
  • each subunit 11 is configured to place only one piece of drug, and the weight in the subunit 11 is removed after the drug is removed.
  • the processing module 20 may be configured to respond to the weight of the medicine in the subunit 11 detected after the user's take-out operation is zero, according to the sub-unit 11 detected before the user's take-out operation
  • the type of drug determines the type and amount of drug taken from the subunit 11 (i.e., 1).
  • the medicine taken out from the medicine container 10 can be determined by counting the type and amount of the medicine in each subunit in which the type of the medicine is detected and detecting that the weight of the medicine is zero (for example, adding the same type of quantity) Type and quantity.
  • the processing module 20 can be configured to determine whether a medication has occurred during the dosing time, ie, whether a drug has been removed from the drug container 10. For example, the processing module 20 determines whether the medicine in each of the subunits 11 is taken out by using information on the total weight of the medicine in the subunit 11 detected by the weight meter 42 during the medication period. For example, if the total weight of the drug in the subunit 11 is decreased, it is determined that the drug in the subunit 11 is taken out, and if not, it is determined that the drug is not taken out.
  • the drug monitoring device 200 may further include a storage module 50.
  • the spectrum and the weight of the plurality of drugs can be pre-stored in the storage module 50.
  • the storage module 50 may store at least a drug spectrum library, a drug weight database, and medication information, wherein the medication information includes at least a medication time, a type and a quantity of the medication to be taken corresponding to the medication time.
  • the drug detecting device 200 may further include a prompting module 60 for issuing specific prompt information.
  • the processing module 20 may use the prompting module 60 to issue the first prompt information ( For example, an alarm or vibration is issued to alert the patient that the drug has been dispensed incorrectly, and the patient is asked to re-distribute it.
  • the prompting module 60 may use the prompting module 60 to issue the first prompt information ( For example, an alarm or vibration is issued to alert the patient that the drug has been dispensed incorrectly, and the patient is asked to re-distribute it.
  • the prompting module 60 can be utilized.
  • a second prompt message is issued, for example to prompt the user to take the medicine.
  • the process can be set to be performed within a specific period of time according to actual needs, for example, only during the period of taking the drug (for example, 8:00-8:30, 12:00-12:30, etc.). This particular time period can be stored, for example, in the storage module 50 as medication information.
  • the medication information may also include information such as the type and amount of the medication to be taken corresponding to the medication time.
  • the processing module 20 may perform classification and statistics according to the determined drug type, and obtain a total of several drugs in the drug container 10, the amount of each drug, and monitor the change of the drug weight information in a specific medication period, and determine the patient.
  • the type and amount of the drug to be taken are compared with the medication information pre-stored in the storage module 50 to determine whether the medication taken by the patient is correct. If the type and quantity of the drug are correct, you can prompt the user to take the drug without prompting. If one of the types and the quantities of the drugs or both are in error, the prompting module 60 may be used to issue a third prompt message to prompt the user to check the type and quantity of the removed medicine.
  • the drug detecting device 200 may further include a communication module 70.
  • communication module 70 can be coupled to processing module 20 and in communication with external electronic devices.
  • the communication module 70 can transmit the prompt signal output by the processing module 20 to the electronic device in communication with the drug monitoring device and receive the medication information transmitted from the electronic device, wherein the medication information includes at least the time of administration, the type and amount of the medication taken.
  • each of the modules may be a soft module or a hardware module.
  • the software modules can be executed on an electronic device to implement corresponding functions.
  • the functions corresponding to each module can be realized by specific components.
  • the Raman analyzer can be used to identify the spectral characteristics of the drug in the box according to different spectra, and compare with the previously known drug library to obtain the types of the drugs, thereby avoiding the patient's misuse due to misplaced drugs or mistaking drugs. problem;
  • the weight meter to detect the weight information of the drug in the subunit, remind the patient to take the medicine during the medication period, and ensure that the quantity of the medicine is consistent with the preset amount.
  • the drug monitoring device provided by the embodiment of the present disclosure, when the tablet is placed in the subunit, it is easy to mistakenly put a plurality of tablets into the same box, causing the patient to misuse and accidentally taking the wrong drug when taking the medicine. The type or quantity leads to misuse.
  • FIG. 3 illustrates an exemplary structural diagram of a medication monitoring system 300 in accordance with some embodiments of the present disclosure.
  • the medication monitoring system 300 can include a medication monitoring device 200 and one or more electronic devices (eg, mobile terminals) 80.
  • Electronic devices include, but are not limited to, smart electronic devices.
  • Electronic devices include, but are not limited to, mobile phones, iPads, tablets, and the like.
  • the user can be the patient himself.
  • the user may include the patient's family, friends, caregivers, and the like in addition to the patient himself.
  • the sending manner of the first prompt information may further include, for example, the second electronic device (the mobile phone of the family member) sends a message to the first electronic device (the mobile phone of the patient), prompting the patient that the drug is distributed incorrectly. Ask the patient to check and redistribute.
  • the drug monitoring device 200 and the electronic device 80 can interact by wireless transmission (mobile internet, Bluetooth, etc.).
  • the electronic devices 80 can also interact between each other by wireless transmission (mobile internet).
  • the electronic device 80 includes another prompting module, and the prompting module can also be used to issue specific prompt information (for example, by a specific ringtone or vibration mode), and the specific prompt information includes the first, second, and third prompt information.
  • the electronic device 80 may include a prompting module (not shown), and the first prompting information may be simultaneously issued by the electronic device 80.
  • the specific implementation process may be, for example, the processing module 20 sends the analysis result to the electronic device 80 by using the communication module 70 by means of wireless transmission (Bluetooth, WiFi, mobile Internet, etc.), and the electronic device 80 is based on the pre-defined according to the analysis result received by the electronic device 80.
  • the method uses another prompt module to issue a first prompt message, prompting the user to check whether the drug classification is incorrect.
  • the predetermined manner for example, may include a particular ringtone.
  • the electronic device 80 can also store the medication information by using the self-contained storage module, and the medication information includes at least the medication time, the type and quantity of the medication each time. Then, the electronic device 80 can receive only the information of the type and quantity of the medicine sent by the processing module 20, and judge whether the information matches the medication information stored in the storage module by the processing module provided by the processing module, and then issue specific prompt information according to the judgment result.
  • FIG. 5 is a schematic flow diagram of a medication monitoring method in accordance with some embodiments of the present disclosure.
  • the method is performed, for example, by one or more components of the drug detection device and drug detection system shown in Figures 1-3.
  • the method includes, for example, the following steps:
  • step S500 the type and amount of the drug placed in the container is determined.
  • Step S502 it is judged whether the determined type and quantity of the medicine placed in the medicine container coincide with the type and quantity of the preset medicine.
  • Step S504 in response to the determination that the type and quantity of the medicine placed in the medicine container does not match the type and quantity of the preset medicine, the first prompt is output.
  • the first prompt is used, for example, to indicate that the type and amount of the drug is incorrect and cannot be taken.
  • the method can further include determining whether at least one of the subunits comprises more than two drugs after detecting the type of the drug in each subunit of the container.
  • the second prompt is output. The second prompt is used, for example, to prompt the patient that the drug is dispensed incorrectly, and the patient is asked to re-distribute after inspection.
  • FIG. 6 is a schematic flow diagram of a medication monitoring method in accordance with some embodiments of the present disclosure.
  • the method is performed, for example, by one or more components of the drug detection device and drug detection system shown in Figures 1-3.
  • the method includes, for example, the following steps:
  • the first prompt is output according to the determination that the type and quantity of the medicine taken out from the medicine container do not match the type and quantity of the preset medicine.
  • the first prompt for example, is used to prompt the removal of the type and amount of the drug, and cannot be taken.
  • the method can further include determining whether at least one of the subunits comprises more than two drugs after detecting the type of the drug in each subunit of the container.
  • the second prompt is output. The second prompt is used, for example, to prompt the patient that the drug is dispensed incorrectly, and the patient is asked to re-distribute after inspection.
  • the method can also include determining if the drug is removed from the container.
  • a third prompt message is issued after it is determined that no drug is taken out of the container.
  • the third prompt information is used, for example, to remind the user who has forgotten to take the medicine to take the medicine.
  • FIG. 7 shows a schematic flow chart of a drug monitoring method in accordance with some embodiments of the present disclosure. The method is performed, for example, by one or more components of the drug detection device and drug detection system shown in Figures 1-3.
  • the method may include the following steps:
  • Step S701 collecting spectral information of drugs in each subunit
  • Step S702 comparing the collected spectral information with the spectral information in the drug spectrum library and determining the type of the drug in each subunit.
  • the kind of the medicine in each subunit in the medicine container can be obtained.
  • the method may further include:
  • Step S703 when two or more drugs are included in one or more subunits, the first prompt information is issued.
  • the first prompt information may be issued by the prompting module 60 shown in FIG. 2, or may be issued by the prompting module in the electronic device 80 shown in FIG.
  • the method can include:
  • Step S704 collecting weight information of drugs in each subunit
  • Step S705 the amount of each drug in the subunit 11 is obtained by using the collected weight information and the piece weight information of the pre-stored medicine.
  • the number of drugs in each subunit can be obtained by step S704 and step S705.
  • the method can include:
  • Step S705 judging whether the medicine in the subunit is taken out according to whether the weight information of the medicine in the subunit changes; this step is mainly realized by judging whether the weight information of the medicine in each subunit 11 changes.
  • Step S707 if no medicine is taken out in the subunit, the second prompt information is sent. Similar to step S703, the second prompt information may be issued by the prompting module 60 located at the medication monitoring device 200 and/or another prompting module of the electronic device 80.
  • Step S708 in the case where the medicine is taken out from the subunit, it is judged whether or not the medicine taken out from the subunit coincides with the type and quantity of the preset medicine.
  • Step S710 if the medicine taken out from the subunit does not match the type and/or quantity of the preset medicine, the third prompt information is issued. Similar to step S703, the third prompt information may be issued by the prompting module 60 located at the medication monitoring device 200 and/or another prompting module of the electronic device 80.
  • embodiments of the present disclosure include at least one of the following advantages:
  • the Raman analyzer can be used to identify the spectral characteristics of the drug in the box according to different spectra, and compare with the drug spectrum library in the storage module to obtain the types of the drugs, thereby avoiding the patient's misuse due to misplaced drugs or mistaking drugs.
  • the weight meter to detect the weight information of the drug in the subunit, remind the patient to take the medicine during the medication period, and ensure that the quantity of the medicine is consistent with the preset amount.
  • the drug monitoring device provided by the embodiment of the present disclosure, it is possible to avoid mistakenly putting a plurality of tablets into the same box when the tablet is placed in the medicine box, thereby causing the patient to misuse and accidentally taking the wrong medicine when taking the medicine.
  • the type or quantity leads to misuse.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmacology & Pharmacy (AREA)

Abstract

一种药物监测装置（100）。该药物监测装置（100）包括：药物分析仪（40），配置为检测药物的类型参数和数量参数；和与药物分析仪（40）耦合的处理模块（20）。处理模块配置（20）为基于检测到的药物的类型参数和数量参数确定检测到的药物的类型和数量，获取预设的药物的类型和数量，和判断检测到的药物的类型和数量是否与预设的药物的类型和数量相符。一种运用所述装置（100）进行药物监测的方法。一种药物检测系统(300)，包括所述药物监测装置（100），和与药物监测装置（100）通信的电子设备（80），二者通过通信模块（70）交互。

Description

药物监测装置、系统及方法
相关申请的交叉引用
本申请要求于2017年3月16日提交的中国专利申请第201710157533.4号的优先权，该申请的公开通过引用被全部结合于此。
技术领域
本公开涉及一种药物监测装置、系统及方法。
背景技术
当代社会，随着生活压力的日益加重，患有生理或心理等慢性病的人群在不断扩大，因此常常需要通过长期服用药物抑制病情。其中，相当一部分中、青年由于生活节奏过快、工作忙碌，经常会忘记服药。另外，对于病情严重的人，可能一天要服用的药物有五六种甚至十几种，而每种药物需要服用的数量不同，需要服用的次数也不同，导致病人很难记清是否已经吃药。此外，很多药物的名称以化学成分或者音译命名，很多病人多这些拗口的名字很难记准、记清，这会导致吃错药。对于老年人来说，多数眼睛已花，很多时候看不清药物的名称，对于颗粒较小的药片，甚至很难数清药片的数量。
发明内容
根据本公开的一些实施例，提供一种药物监测装置，包括：药物分析仪，配置为检测药物的类型参数和数量参数和与药物分析仪耦合的处理模块。处理模块被配置为：基于检测到的药物的类型参数和数量参数确定检测到的药物的类型和数量，获取预设的药物的类型和数量，和判断检测到的药物的类型和数量是否与预设的药物的类型和数量相符。
根据本公开的一些实施例，药物分析仪被配置为检测放入盛药容器中的药物的类型参数和数量参数。
根据本公开的一些实施例，药物分析仪被配置为检测从盛药容器中取出的药物的类型参数和数量参数。
根据本公开的一些实施例，所述药物分析仪包括：拉曼分析仪，其包括激光器和激光检测装置，其中，激光器发射的激光能够照射到药物的表面，激光检测装置能够接收反射回的激光并获得药物的光谱；和重量计，被配置为检测盛药容器中的药物的重量。
根据本公开的一些实施例，药物监测装置还包括所述盛药容器，其中所述盛药容器包括用于盛放药物的至少一个子单元，其中每个子单元设置有通孔，并具有对应设置的激光器和激光检测装置，激光器被配置为发射激光通过所述通孔照射至该子单元中的药物的表面，激光检测装置能够接收通过所述通孔反射回的激光并获得该子单元中的药物的光谱；其中每个子单元具有对应设置的重量计，被配置为检测该子单元中的药物的重量。
根据本公开的一些实施例，所述药物监测装置还包括存储模块，所述存储模块中预存有多种药物的光谱和单片重量。
根据本公开的一些实施例，所述处理模块还被配置为：基于检测出的每个子单元中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元中的药物的类型，利用检测出的该子单元中的药物的重量与该类型的药物的单片重量来计算该子单元中的该药物的数量，从而确定放入盛药容器中的药物的类型和数量。
根据本公开的一些实施例，在药物分析仪被配置为检测从盛药容器中取出的药物的类型参数和数量参数的情况下，所述处理模块还被配置为：基于在用户的取出操作之前检测出的每个子单元中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元中的药物的类型，根据在用户的取出操作之前检测出的该子单元中的该类型的药物的重量、在用户的取出操作之后检测到的该子单元中的该类型的药物的重量以及该类型的药物的单片重量，计算出所取出的该类型的药物的数量，从而确定从盛药容器取出的药物的类型和数量。
根据本公开的一些实施例，每个子单元被设置为只允许放置一片药物，所述处理模块还被配置为：响应于在用户的取出操作之后检测出的子单元中的药物的重量为零，根据在用户的取出操作之前检测出的该子单元中的药物的类型确定从该子单元取出的药物的类型和数量，从而确定从盛药容器取出的药物的类型和数量。
根据本公开的一些实施例，处理模块被配置为响应于判定检测到的药物的类型和 数量与预设的药物的类型和数量不相符，输出提示信号。
根据本公开的一些实施例，药物监测装置还包括：与处理模块耦合的提示模块，被配置为基于处理模块输出的提示信号向用户呈现提示。
根据本公开的一些实施例，药物监测装置还包括与处理模块耦合的通信模块，被配置为：将处理模块输出的提示信号发送给与药物监测装置通信的电子设备，和接收从电子设备发送的服药信息，其中服药信息至少包括服药时间、服用药物的类型和数量。
根据本公开的一些实施例，提供一种药物监测系统，包括如上所述的药物监测装置和与药物监测装置通信的电子设备，其中，药物监测装置经由所述通信装置与所述电子设备交互。
根据本公开的一些实施例，提供一种药物监测方法，包括以下步骤：确定放入盛药容器中的药物的类型和数量；判断确定的放入盛药容器中的药物的类型和数量是否与预设的药物的类型和数量相符；响应于判定确定的放入盛药容器中的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。
根据本公开的一些实施例，该药物监测方法还包括：响应于确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物，输出第二提示。
根据本公开的一些实施例，还提供一种药物监测方法，包括：确定从盛药容器中取出的药物的类型和数量；判断确定的从盛药容器中取出的药物的类型和数量是否与预设的药物的类型和数量相符；响应于判定确定的从盛药容器中取出的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。
根据本公开的一些实施例，该药物监测方法还包括：响应于确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物，输出第二提示。
根据本公开的一些实施例，该药物监测方法还包括：响应于确定没有药物从盛药容器中被取出，发出第三提示信息。
附图说明
图1是根据本公开一些实施例的药物监测装置的示例性结构框图；
图2是根据本公开一些实施例的药物监测装置的示例性结构框图；
图3是根据本公开一些实施例的药物监测系统的示例性结构框图；
图4是根据本公开一些实施例的药物监测装置的盛药容器的示例性结构的俯视示意图；
图5是根据本公开一些实施例的药物监测方法的示意性流程图；
图6是根据本公开一些实施例的药物监测方法的示意性流程图；
图7是根据本公开一些实施例的药物监测方法的示意性流程图。
具体实施方式
为使本公开的上述目的、特征和优点能够更加明显易懂，下面结合附图和具体实施方式对本公开作进一步详细的说明。
根据本公开一些实施例，提供一种药物监测装置。图1示出了根据本公开一些实施例的药物监测装置100的示例性结构框图。如图1所示，该装置100包括药物分析仪40和处理模块20。药物分析仪40能够检测药物的类型参数和数量参数。处理模块20与药物分析仪40耦合，并且能够基于检测到的药物的类型参数和数量参数确定检测到的药物的类型和数量，获取预设的药物的类型和数量，和判断检测到的药物的类型和数量是否与预设的药物的类型和数量相符。
在一些实施例中，药物分析仪40可以检测放入盛药容器(图1中未示出)中的药物的类型参数和数量参数。处理模块20可以根据药物分析仪40检测到的放入盛药容器(图1中未示出)中的药物的类型参数和数量参数来确定放入盛药容器中的药物的类型参数和数量，并判断放入盛药容器中的药物的类型参数和数量是否与预设的药物的类型和数量相符。
在另一些实施例中，药物分析仪40可以检测从盛药容器中取出的药物的类型参数和数量参数。这里如可以通过检测盛药容器中原始的药物的类型参数和数量参数以及在取出操作之后盛药容器中的药物的类型参数和数量参数并将这些参数进行比较来确定。处理模块20可以根据药物分析仪40检测到的从盛药容器中取出的药物的类型参数和数量参数来确定从盛药容器中取出的药物的类型和数量，并判断从盛药容器中取出的药物的类型和数量是否与预设的药物的类型和数量相符。
图2示出了根据本公开一些实施例的药物监测装置200的示例性结构框图。如图2 所示，与图1类似，药物监测装置200包括处理模块20和药物分析仪40。
药物分析仪40例如可以包括拉曼分析仪41和重量计42。拉曼分析仪41可以包括激光器411和激光检测装置412。激光器411发射的激光能够照射到药物的表面。激光检测装置412能够接收被例如盛药容器10中的药物反射回的激光并获得药物的光谱，以作为类型参数供所述处理模块20用于确定所述被照射药物的类型。重量计42例如用于采集盛药容器10中的药物的重量，来作为数量参数供所述处理模块20用于确定所述被照射药物的数量。
处理模块20可以获取药物分析仪40中的拉曼分析仪41和重量计42所检测到的药物的类型参数和数量参数，将获得药物的类型参数和数量参数与预设的类型参数(例如预设的光谱)和数量参数(预设的药物单片重量)进行比较，来确定检测到的药物的类型和数量。处理模块20还可以将确定的检测到的药物的类型和数量与预设的药物的类型和数量进行比较，来判断判断检测到的药物的类型和数量是否与预设的药物的类型和数量相符。
药物监测装置200还可以包括用于盛放药物的盛药容器10。
图4中示出根据本公开一些实施例的盛药容器的示例性构造的俯视图。如图4所示，盛药容器10可以包括用于盛放药物的至少一个子单元11。每一个子单元11例如可以用于盛放同一种类药物，但不限于此。每一个子单元可以用于盛放不同种类的药物。
每个子单元11设置有通孔12，并具有对应设置的激光器411和激光检测装置412，激光器411被配置为发射激光通过所述通孔12照射至该子单元11中的药物的表面，激光检测装置412能够接收通过所述通孔12反射回的激光并获得该子单元11中的药物的光谱。
例如，子单元11底部设置有通孔12。可以设置多个激光器411且激光器411可以与每一子单元11对应地设置。激光器411用于发射激光通过所述通孔12照射至该子单元11中药物的表面。各个子单元11底部分别开设的通孔12可以具有特定尺寸。例如，通孔12的尺寸可以根据实际药物形状的大小设置，确保既可以透过激光，使激光照射到药物表面，又可以保证药物不从通孔12漏下去。
处理模块20例如可以利用拉曼分析仪41(例如包括激光器11和激光检测装置412)通过如下过程来获取每个子单元11中的药物的类型。位于子单元11底部的激光器411 发出激光，激光可以通过子单元11底部设置的通孔12照射到子单元11内的药物上。例如当子单元11中只有1个药片时，激光打到该药片。当子单元11中有多个药片时，激光可以打到任意一个药片，即可以打到所有药片。根据光的反射原理，激光打到药物上后会发生反射，反射光被激光检测装置412接收。于是，拉曼分析仪41利用拉曼散射原理对反射回的光进行分析，得到该药物的拉曼光谱。处理模块20可以比对拉曼分析仪41得到的拉曼光谱和预先确定的药物光谱库来确定子单元11中药物的种类。预先确定的药物光谱库例如可以是从外部数据库获取的，也可以是预先存储在例如存储模块50中的。
对于多个子单元，可以同时或依次获取各自子单元11内的药物种类。
每个子单元11可以具有对应设置的重量计，被配置为检测该子单元中的药物的重量。即，可以设置多个重量计42且重量计42可以与每一个子单元11对应地设置。重量计42采集子单元11中药物的重量。
处理模块20例如可以利用重量计42通过如下过程来获取每个子单元11中的药物的数量。在一些实施例中，重量计42检测子单元11中药物的重量，处理模块20利用如上所述确定的子单元11中药物的类型、由重量计42检测到的子单元11中药物的重量以及预先确定的该类型药物的单片重量来计算子单元11中药物的数量。
处理模块20例如可以利用重量计42通过如下过程来获取从每个子单元11中取出的药物的数量。在一些实施例中，重量计42检测取出操作之前子单元11中药物的重量以及取出操作之后子单元11中药物的重量，处理模块20利用如上所述确定的子单元11中药物的类型、由重量计42检测到的取出操作前后子单元11中药物的重量差以及预先确定的该类型药物的单片重量来计算从子单元11中取出的药物的数量。
例如，在一些实施例中，处理模块20首先利用药物分析仪确定各个子单元11中所盛药物的种类，在已知药物种类的前提下，利用重量计42采集各个子单元11中药物的重量信息(例如：药物的总重量)。然后根据预先确定的每种药物的单片重量信息，用药物总重量除以单片重量来获得每种药物的数量。
在一些实施例中，处理模块20可以基于检测出的每个子单元11中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元11中的药物的类型，利用检测出的该子单元11中的药物的重量与该类型的药物的单片重量来计算该子单元11中的该药物的数 量，从而确定放入盛药容器10中的药物的类型和数量。
在一些实施例中，药物分析仪被配置为检测从盛药容器10中取出的药物的类型参数(例如光谱)和数量参数(例如重量)，处理模块20可以被配置为基于在用户的取出操作之前检测出的每个子单元11中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元11中的药物的类型，根据在用户的取出操作之前检测出的该子单元11中的该类型的药物的重量、在用户的取出操作之后检测到的该子单元中的该类型的药物的重量以及该类型的药物的单片重量，计算出所取出的该类型的药物的数量，从而确定从盛药容器10取出的药物的类型和数量。
在一些实施例中，每一个子单元11被配置为只放置一片药物，则子单元11中的药物后被取出后重量变为零。在这种情况下，处理模块20可以被配置为响应于在用户的取出操作之后检测出的子单元11中的药物的重量为零，根据在用户的取出操作之前检测出的该子单元11中的药物的类型确定从该子单元11取出的药物的类型和数量(即为1)。通过将在其中检测到药物的类型并且检测到药物的重量为零的各个子单元中的药物的类型和数量进行统计(例如相同类型的数量进行相加)可以确定从盛药容器10取出的药物的类型和数量。
在一些实施例中，处理模块20可以被配置为判断在服药时间内是否发生服药，即是否有药物从盛药容器10中被取出。例如，处理模块20利用重量计42在服药时间段内检测到的与子单元11内药物的总重量有关的信息，判断各个子单元11中的药物是否被取出。例如，若子单元11内药物总重量减小，则确定子单元11内有药物被取出，若否，则确定药物未被取出。
如图2所示，可选地，药物监测装置200还可以包括存储模块50。存储模块50中可以预存有多种药物的光谱和单片重量。存储模块50中可以至少存储有药物光谱库、药物重量数据库以及服药信息，其中，服药信息至少包括服药时间、与服药时间对应的需要服用的药物的种类及数量。
如图2所示，可选地，药物检测装置200还可以包括提示模块60，所述提示模块60用于发出特定提示信息。
例如，当处理模块20获取各个子单元11中药物的种类后，若发现某一个甚至是多个子单元11中发现存在两种以上药物时，处理模块20可以利用提示模块60发出第一提 示信息(例如：发出警铃或者震动)，来提示患者药物分发有误，请患者检查后重新分发。
例如，当处理模块20利用重量计42在服药时间段内检测到的与子单元11内药物的总重量有关的信息，判断各个子单元11中药物都未被取出时，则可以利用提示模块60发出第二提示信息，例如来提示用户服药。该过程可以根据实际需要设定为在特定时间段内进行，例如仅在服用药物的时段(例如：8:00-8:30、12:00-12:30等)进行检测。该特定时间段例如可以存储在存储模块50中作为服药信息。除此之外，服药信息还可以包括与服药时间对应的需要服用的药物的种类和数量等信息。
又例如，处理模块20可以根据确定的药物种类进行分类统计，得到盛药容器10中一共有几种药物、每种药物的数量为多少，并监测特定服药时间段药物重量信息的变化，确定病人服用的药物种类和数量并与预先存储在存储模块50中的服药信息对比，判断病人此次服用的药物是否正确。如果药物的种类和数量均无误，则可以不做出提示也可以提示用户可以服用药物。如果药物的种类和数量中的一个信息或者两者同时出错，则可以利用提示模块60发出第三提示信息，来提示用户检查取出药物的种类以及数量。
如图2所示，可选地，药物检测装置200还可以包括通信模块70。例如，通信模块70可以与处理模块20耦合并与外部电子设备通信。例如，通信模块70可以将处理模块20输出的提示信号发送给与药物监测装置通信的电子设备以及接收从电子设备发送的服药信息，其中服药信息至少包括服药时间、服用药物的类型和数量。
值得注意的是，所述各个模块，可以为软模块也可以为硬件模块。当上述模块是通过计算机程序语言实现的软件模块时，这些软件模块可以在电子装置上执行，以实现对应的功能。当上述模块是通过硬件电路实现的硬件模块时，通过特定的元件可以实现每个模块对应的功能。
与相关技术相比，本公开实施例至少包括以下优点中的一个或多个：
首先，可以利用拉曼分析仪根据不同的光谱识别盒内药物的光谱特征，并与预先知道的药品光谱库对比获得各个药物的种类进而实现避免患者因放错药物或者取错药物造成误服的问题；
其次，还可以利用重量计检测子单元内药物的重量信息，在服药时间段内提醒患者服药，同时确保服用药物的数量与预先设定的数量相符。
利用本公开实施例提供的药物监测装置，可以避免在把药片放到子单元时，容易错把多种药片放入同一盒子中，导致患者误服以及在取药服用时，不小心取错药物种类或者数量导致误服。
图3示出根据本公开一些实施例的药物监测系统300的示例性结构图。如图3所示，该药物监测系统300可以包括药物监测装置200以及一个或多个电子设备(例如：移动终端)80。电子设备包括但不限于智能电子设备。电子设备包括但不限于手机、iPad、平板电脑等。
若只有一个电子设备80时，使用者可以是患者本人。若涉及多个电子设备80时，其使用者除患者本人外，还可以包括患者的家人、朋友以及护理人员等。在第二种情况下，上述第一提示信息的发送方式还可以包括，例如：第二电子设备(家人的手机)向第一电子设备(患者的手机)发送信息，提示患者药物分发有误，请患者检查后重新分发。
利用通信模块70，所述药物监测装置200与电子设备80可以通过无线传输方式(移动互联网、蓝牙等方式)交互。电子设备80之间也可以通过无线传输方式(移动互联网)交互。优选地，该电子设备80包括另一提示模块，该提示模块也可以用于发出特定提示信息(例如通过特定铃声或者震动方式)，特定提示信息包括上述第一、第二以及第三提示信息。
可选地，电子设备80可以包括提示模块(未示出)，上述第一提示信息可以同时由电子设备80发出。具体实现过程例如可以为：处理模块20利用通信模块70通过无线传输方式(蓝牙、WiFi、移动互联网等方式)向电子设备80发送分析结果，电子设备80根据其接收到的分析结果基于预先规定好的方式利用另一提示模块发出第一提示信息，提示用户检查药物分类是否有误。该预先规定好的方式，例如可以包括某一特定铃声。
此外，电子设备80还可以利用自带的存储模块存储服药信息，该服药信息至少包括服药时间、每次服用药物的种类及数量。那么，电子设备80可以仅接收处理模块20发送的药物种类和数量的信息，并通过自带的处理模块判断该信息是否与其存储模块存 储的服药信息相符，然后根据判断结果发出特定提示信息。
图5是根据本公开一些实施例的药物监测方法的示意性流程图。该方法例如通过图1-3中所示的药物检测装置和药物检测系统中的一个或多个组件来执行。该方法例如包括以下步骤：
步骤S500，确定放入盛药容器中的药物的类型和数量。
步骤S502，判断确定的放入盛药容器中的药物的类型和数量是否与预设的药物的类型和数量相符。
步骤S504，响应于判定确定的放入盛药容器中的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。第一提示例如用于提示药物类型和数量有误，不能服用。
在一些实施例中，该方法还可以包括在检测盛药容器各子单元中的药物的类型之后，确定盛药容器中是否有至少一个子单元中包括两种以上的药物。在确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物的情况下，输出第二提示。第二提示例如用于提示患者药物分发有误，请患者检查后重新分发。
图6是根据本公开一些实施例的药物监测方法的示意性流程图。该方法例如通过图1-3中所示的药物检测装置和药物检测系统中的一个或多个组件来执行。该方法例如包括以下步骤：
S600，确定从盛药容器中取出的药物的类型和数量；
S602，判断确定的从盛药容器中取出的药物的类型和数量是否与预设的药物的类型和数量相符；
S604，响应于判定确定的从盛药容器中取出的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。第一提示例如用于提示取出的药物类型和数量有误，不能服用。
在一些实施例中，该方法还可以包括在检测盛药容器各子单元中的药物的类型之后，确定盛药容器中是否有至少一个子单元中包括两种以上的药物。在确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物的情况下，输出第二提示。第二提示例如用于提示患者药物分发有误，请患者检查后重新分发。
在一些实施例中，该方法还可以包括确定有没有药物从盛药容器中被取出。在确定没有药物从盛药容器中被取出，发出第三提示信息。第三提示信息例如用于提醒忘记服药的用户需要服药。
图7示出根据本公开一些实施例的药物监测方法的示意性流程图。该方法例如通过图1-3中所示的药物检测装置和药物检测系统中的一个或多个组件来执行。
如图7所示，该方法可以包括以下步骤：
步骤S701，采集各个子单元中药物的光谱信息；
步骤S702，对比采集到的光谱信息与药物光谱库中的光谱信息并确定各个子单元中药物的种类。
通过步骤S701和S702，例如可以获得盛药容器中各子单元中的药物的种类。
可选地，该方法还可以包括：
步骤S703，当一个或多个子单元中包括两种以上的药物时，则发出第一提示信息。如上所述，第一提示信息可以由图2中所示的提示模块60发出，也可以由图3中所示的电子设备80中的提示模块发出。
该方法可以包括：
步骤S704，采集各个子单元中药物的重量信息；
步骤S705，利用采集到的重量信息以及预先存储的药物的单片重量信息获得子单元11中每种药物的数量。
通过步骤S704和步骤S705可以获取各个子单元中药物的数量。
该方法可以包括：
步骤S705，根据子单元中药物的重量信息是否发生变化判断子单元中的药物是否被取出；这一步骤主要通过判断各个子单元11中药物的重量信息是否发生变化来实现。
步骤S707，若子单元中没有药物被取出，则发出第二提示信息。与步骤S703类似，该第二提示信息可以由位于药物监测装置200的提示模块60和/或电子设备80的另一提示模块发出。
步骤S708，在药物被从子单元中取出的情况下，判断从子单元中取出的药物是否与预设的药物的种类和数量相符。
步骤S710，若从子单元中取出的药物与预设的药物的种类和/或数量不相符，则发出第三提示信息。与步骤S703类似，该第三提示信息可以由位于药物监测装置200的提示模块60和/或电子设备80的另一提示模块发出。
与相关技术相比，本公开实施例至少包括以下优点中的至少一个：
首先，可以利用拉曼分析仪根据不同的光谱识别盒内药物的光谱特征，并与存储模块中的药品光谱库对比获得各个药物的种类进而实现避免患者因放错药物或者取错药物造成误服的问题；
其次，还可以利用重量计检测子单元内药物的重量信息，在服药时间段内提醒患者服药，同时确保服用药物的数量与预先设定的数量相符。
利用本公开实施例提供的药物监测装置，可以避免在把药片放入药盒时，容易错把多种药片放入同一盒子中，导致患者误服以及在取药服用时，不小心取错药物种类或者数量导致误服。
本说明书中的各个实施例均采用递进的方式描述，每个实施例重点说明的都是与其他实施例的不同之处，各个实施例之间相同相似的部分互相参见即可。对于系统实施例而言，由于其与方法实施例基本相似，所以描述的比较简单，相关之处参见方法实施例的部分说明即可。
以上对本公开所提供的药物监测装置、系统及方法，进行了详细介绍，本文中应用了具体个例对本公开的原理及实施方式进行了阐述，以上实施例的说明只是用于帮助理解本公开的方法及其核心思想；同时，对于本领域的一般技术人员，依据本公开的思想，在具体实施方式及应用范围上均会有改变之处，综上所述，本说明书内容不应理解为对本公开的限制。

Claims (18)

  1. 一种药物监测装置，包括：
    药物分析仪，配置为检测药物的类型参数和数量参数；和
    与药物分析仪耦合的处理模块，配置为：
    基于检测到的药物的类型参数和数量参数确定检测到的药物的类型和数量，
    获取预设的药物的类型和数量，和
    判断检测到的药物的类型和数量是否与预设的药物的类型和数量相符。
  2. 根据权利要求1所述的药物监测装置，其中，
    药物分析仪被配置为检测放入盛药容器中的药物的类型参数和数量参数。
  3. 根据权利要求1所述的药物监测装置，其中，
    药物分析仪被配置为检测从盛药容器中取出的药物的类型参数和数量参数。
  4. 如权利要求2或3所述的药物监测装置，其中，所述药物分析仪包括：
    拉曼分析仪，其包括激光器和激光检测装置，其中，激光器发射的激光能够照射到药物的表面，激光检测装置能够接收反射回的激光并获得药物的光谱；和
    重量计，被配置为检测盛药容器中的药物的重量。
  5. 根据权利要求4所述的药物监测装置，还包括所述盛药容器，
    其中所述盛药容器包括用于盛放药物的至少一个子单元，
    其中每个子单元设置有通孔，并具有对应设置的激光器和激光检测装置，激光器被配置为发射激光通过所述通孔照射至该子单元中的药物的表面，激光检测装置能够接收通过所述通孔反射回的激光并获得该子单元中的药物的光谱；
    其中每个子单元具有对应设置的重量计，被配置为检测该子单元中的药物的重量。
  6. 根据权利要求5所述的药物监测装置，其中，所述药物监测装置还包括存储模块，所述存储模块中预存有多种药物的光谱和单片重量。
  7. 根据权利要求6所述的药物监测装置，其中，所述处理模块还被配置为：
    基于检测出的每个子单元中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元中的药物的类型，
    利用检测出的该子单元中的药物的重量与该类型的药物的单片重量来计算该子单元中的该药物的数量，
    从而确定放入盛药容器中的药物的类型和数量。
  8. 根据权利要求6所述的药物监测装置，其中，在药物分析仪被配置为检测从盛药容器中取出的药物的类型参数和数量参数的情况下，所述处理模块还被配置为：
    基于在用户的取出操作之前检测出的每个子单元中的药物的光谱与预存的药物的光谱之间的匹配来确定该子单元中的药物的类型，
    根据在用户的取出操作之前检测出的该子单元中的该类型的药物的重量、在用户的取出操作之后检测到的该子单元中的该类型的药物的重量以及该类型的药物的单片重量，计算出所取出的该类型的药物的数量，
    从而确定从盛药容器取出的药物的类型和数量。
  9. 根据权利要求8所述的药物监测装置，其中，每个子单元被设置为只允许放置一片药物，所述处理模块还被配置为：
    响应于在用户的取出操作之后检测出的子单元中的药物的重量为零，根据在用户的取出操作之前检测出的该子单元中的药物的类型确定从该子单元取出的药物的类型和数量，
    从而确定从盛药容器取出的药物的类型和数量。
  10. 如权利要求1-9中任一项所述的药物监测装置，其中，处理模块被配置为响应于判定检测到的药物的类型和数量与预设的药物的类型和数量不相符，输出提示信号。
  11. 根据权利要求10所述的药物监测装置，还包括：
    与处理模块耦合的提示模块，被配置为基于处理模块输出的提示信号向用户呈现提示。
  12. 根据权利要求10或11中任一项所述的药物监测装置，还包括与处理模块耦合的通信模块，被配置为：
    将处理模块输出的提示信号发送给与药物监测装置通信的电子设备，和
    接收从电子设备发送的服药信息，其中服药信息至少包括服药时间、服用药物的类型和数量。
  13. 一种药物监测系统，包括：
    如权利要求12所述的药物监测装置，和
    与药物监测装置通信的电子设备，
    其中，药物监测装置经由所述通信装置与所述电子设备交互。
  14. 一种药物监测方法，包括以下步骤：
    确定放入盛药容器中的药物的类型和数量；
    判断确定的放入盛药容器中的药物的类型和数量是否与预设的药物的类型和数量相符；
    响应于判定确定的放入盛药容器中的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。
  15. 如权利要求14所述的药物监测方法，还包括：响应于确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物，输出第二提示。
  16. 一种药物监测方法，包括：
    确定从盛药容器中取出的药物的类型和数量；
    判断确定的从盛药容器中取出的药物的类型和数量是否与预设的药物的类型和数量相符；
    响应于判定确定的从盛药容器中取出的药物的类型和数量与预设的药物的类型和数量不相符，输出第一提示。
  17. 根据权利要求16所述的药物监测方法，还包括：
    响应于确定盛药容器中的至少一个子单元中的每个子单元中包括两种以上的药物，输出第二提示。
  18. 根据权利要求16所述的药物监测方法，还包括：
    响应于确定没有药物从盛药容器中被取出，发出第三提示信息。
PCT/CN2018/077896 2017-03-16 2018-03-02 药物监测装置、系统及方法 WO2018166362A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/087,378 US20190086326A1 (en) 2017-03-16 2018-03-02 Medicine monitoring device, system and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710157533.4A CN106959278A (zh) 2017-03-16 2017-03-16 药物监测装置、系统及方法
CN201710157533.4 2017-03-16

Publications (1)

Publication Number Publication Date
WO2018166362A1 true WO2018166362A1 (zh) 2018-09-20

Family

ID=59471019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/077896 WO2018166362A1 (zh) 2017-03-16 2018-03-02 药物监测装置、系统及方法

Country Status (3)

Country Link
US (1) US20190086326A1 (zh)
CN (1) CN106959278A (zh)
WO (1) WO2018166362A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106959278A (zh) * 2017-03-16 2017-07-18 京东方科技集团股份有限公司 药物监测装置、系统及方法
KR102247243B1 (ko) * 2019-06-11 2021-05-03 김도연 스마트 약통 유닛 및 이를 이용한 스마트 약복용 모니터링 방법
CN113384089A (zh) * 2021-06-24 2021-09-14 广州长峰生物技术有限公司 一种智能药柜及其智能服药提醒方法
CN113633555A (zh) * 2021-08-13 2021-11-12 苏州大学附属儿童医院 具有服药提醒功能的药盒设备及其进行服药管理的方法
CN114139661A (zh) * 2021-10-29 2022-03-04 松下电气设备(中国)有限公司 用药提醒系统及提醒方法
CN114533550B (zh) * 2022-02-28 2024-10-18 郑州大学 一种基于患者个人习惯识别的健康用药管理方法和终端
CN115165777A (zh) * 2022-07-01 2022-10-11 首都医科大学宣武医院 芬太尼类管控麻醉药品废液回收核查系统

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103148918A (zh) * 2012-08-17 2013-06-12 苏州艾隆科技股份有限公司 盘点机
CN103164824A (zh) * 2011-12-13 2013-06-19 苏州艾隆科技有限公司 盘点机系统及提升盘点机系统精度的方法
CN103196889A (zh) * 2013-04-16 2013-07-10 许春 基于微机电系统光谱分析的便携式拉曼光谱仪
US8848173B2 (en) * 2011-11-10 2014-09-30 Cdex, Inc. Chemical and molecular identification and quantification system utilizing enhanced photoemission spectroscopy
CN104535497A (zh) * 2014-12-29 2015-04-22 苏州优谱德精密仪器科技有限公司 一种便携式拉曼光谱仪的收容箱
US9075015B2 (en) * 2012-06-04 2015-07-07 Frederick W. Shapiro Universal tool for automated gem and mineral identification and measurement
CN106370642A (zh) * 2016-08-17 2017-02-01 中国计量大学 一种检测食品和药品专用的便携拉曼光谱仪
CN106395227A (zh) * 2016-02-10 2017-02-15 唐山晟群科技有限公司 一种全药品智能发药机
CN106959278A (zh) * 2017-03-16 2017-07-18 京东方科技集团股份有限公司 药物监测装置、系统及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5200754B2 (ja) * 2008-08-13 2013-06-05 凸版印刷株式会社 有機ケイ素化合物中のケイ素の分析方法
CN103175804A (zh) * 2013-03-04 2013-06-26 广东省中医研究所 一种基于近红外光谱技术布渣叶中黄酮类成分含量的测定方法
CN105395369B (zh) * 2015-11-27 2019-02-26 Oppo广东移动通信有限公司 一种用药提醒方法、终端、药盒装置和系统
CN108732126A (zh) * 2017-04-25 2018-11-02 天士力医药集团股份有限公司 一种采用近红外光谱法测定丹参药材中多成分含量的方法

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8848173B2 (en) * 2011-11-10 2014-09-30 Cdex, Inc. Chemical and molecular identification and quantification system utilizing enhanced photoemission spectroscopy
CN103164824A (zh) * 2011-12-13 2013-06-19 苏州艾隆科技有限公司 盘点机系统及提升盘点机系统精度的方法
US9075015B2 (en) * 2012-06-04 2015-07-07 Frederick W. Shapiro Universal tool for automated gem and mineral identification and measurement
CN103148918A (zh) * 2012-08-17 2013-06-12 苏州艾隆科技股份有限公司 盘点机
CN103196889A (zh) * 2013-04-16 2013-07-10 许春 基于微机电系统光谱分析的便携式拉曼光谱仪
CN104535497A (zh) * 2014-12-29 2015-04-22 苏州优谱德精密仪器科技有限公司 一种便携式拉曼光谱仪的收容箱
CN106395227A (zh) * 2016-02-10 2017-02-15 唐山晟群科技有限公司 一种全药品智能发药机
CN106370642A (zh) * 2016-08-17 2017-02-01 中国计量大学 一种检测食品和药品专用的便携拉曼光谱仪
CN106959278A (zh) * 2017-03-16 2017-07-18 京东方科技集团股份有限公司 药物监测装置、系统及方法

Also Published As

Publication number Publication date
CN106959278A (zh) 2017-07-18
US20190086326A1 (en) 2019-03-21

Similar Documents

Publication Publication Date Title
WO2018166362A1 (zh) 药物监测装置、系统及方法
EP3706705B1 (en) System, method, and module for integrated medication management
CN111161827B (zh) 一种基于智能药盒的用药和病情管理系统
CN106794324B (zh) 具有方位传感器的吸入器
JP2018536449A5 (zh)
CN103767871B (zh) 药品容器及对应的服药提醒系统
US20160026773A1 (en) Methods and Systems of Real-Time Medication Adherence Monitoring
CN109068974A (zh) 具有改善的安全性和有效性特征的阿片样物质+设备组合产品
EP3458013B1 (en) Smart caps for medication containers
US20180056018A1 (en) Inhalation Systems, Devices and Methods
CN106473930A (zh) 一种智能药箱
CN106790236A (zh) 远程智能用药服务系统
CN108538355A (zh) 药物施用确认设备和方法
JP6423810B2 (ja) 服薬支援システム
CN106161632A (zh) 一种个人健康医疗监测系统及健康方法
CN114206296A (zh) 用于药物管理的智能容器、传感器和方法
US20190282450A1 (en) System, method, and module for integrated medication management
CN106580712A (zh) 服药提醒方法及装置
US12046344B2 (en) Systems, methods, and apparatuses for managing adherence to a regimen
WO2020221992A1 (en) Monitoring patient compliance with a dosage regimen
CN106446588A (zh) 医疗监控终端、系统及方法
CN109830292A (zh) 一种移动式急救装置物品监测方法、装置及系统
CN111063414A (zh) 智能药箱与可穿戴设备的交互实现方法及装置
CN116473546A (zh) 基于智能穿戴产品的重症患者监控方法、系统和存储介质
CN204596102U (zh) 一种健康管理电路

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18768076

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18768076

Country of ref document: EP

Kind code of ref document: A1